# Correction: Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors

## TL;DR

This paper corrects a previously published study on the design and testing of chalcone–piperazine compounds as inhibitors of two enzymes linked to neurological diseases.

## Contribution

The correction addresses errors in the original publication to ensure scientific accuracy and reliability.

## Key findings

- The correction clarifies details in the experimental methods and results.
- It ensures the data and conclusions remain valid and trustworthy for future research.

## Abstract

Correction for ‘Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors’ by Berkant Kurban et al., RSC Adv., 2025, 15, 40897–40911, https://doi.org/10.1039/D5RA05397H.